Amarin Corp Plcuk (AMRN) Non-cash Items (2015 - 2025)
Amarin Corp Plcuk (AMRN) reported Non-cash Items of $14.6 million for Q4 2025, up 5.36% year-over-year from $13.8 million in Q4 2024, and up 5.36% quarter-over-quarter from $13.8 million in Q4 2024.
Amarin Corp Plcuk (AMRN) Non-cash Items (2015 - 2025) Analysis & Trends
Amarin Corp Plcuk (AMRN) has 11 years of Non-cash Items data on file, last reported at $14.6 million in Q4 2025.
- Non-cash Items for Q4 2025 came in at $14.6 million, up 5.36% year-over-year; the trailing twelve-month figure through Dec 2025 was $14.6 million (up 5.36% YoY), and the FY2025 annual result was $14.6 million, up 5.36% from the prior year.
- Non-cash Items climbed to $14.6 million in Q4 2025 per AMRN's latest filing, from $13.8 million in the prior quarter.
- Over five years, Non-cash Items peaked at $14.6 million in Q4 2025 and troughed at $158000.0 in Q4 2022.
- A 5-year average of $10.7 million and a median of $12.5 million in 2021 frame the typical range for Non-cash Items.
- The sharpest annual moves came in 2022 and 2023: Non-cash Items plunged 98.73% in 2022, then jumped 7705.7% in 2023.
- A 5-year view of Non-cash Items shows it stood at $12.5 million in 2021, then sank by 98.73% to $158000.0 in 2022, then jumped by 7705.7% to $12.3 million in 2023, then advanced by 12.17% to $13.8 million in 2024, then grew by 5.36% to $14.6 million in 2025.
- Business Quant data shows AMRN's Non-cash Items at $14.6 million in Q4 2025, $13.8 million in Q4 2024, and $12.3 million in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Gsk | 93,699,046.73 Bn | 93,699,041.77 Bn | 7.76 Bn |
| 2 | Eli Lilly | 1,012.06 Bn | 1,006.77 Bn | 16.22 Bn |
| 3 | Johnson & Johnson | 560.67 Bn | 538.62 Bn | 15.96 Bn |
| 4 | AbbVie | 402.20 Bn | 392.85 Bn | 10.78 Bn |
| 5 | Merck | 298.59 Bn | 292.94 Bn | 12.09 Bn |
| 6 | Amgen | 188.77 Bn | 176.74 Bn | 5.87 Bn |
| 7 | Gilead Sciences | 160.22 Bn | 152.49 Bn | 5.52 Bn |
| 8 | Pfizer | 148.19 Bn | 135.42 Bn | -1.21 Bn |
| 9 | Bristol Myers Squibb | 116.72 Bn | 106.26 Bn | 8.07 Bn |
| 10 | Amarin Corp Plcuk | 5.84 Bn | 5.66 Bn | 17.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 14.58 Mn |
| Dec 31, 2025 | 14.58 Mn |
| Dec 31, 2024 | 13.83 Mn |
| Dec 31, 2024 | 13.83 Mn |
| Dec 31, 2023 | 12.33 Mn |
| Dec 31, 2023 | 12.33 Mn |
| Dec 31, 2022 | 158,000.00 |
| Dec 31, 2022 | 158,000.00 |
| Dec 31, 2021 | 12.49 Mn |
| Dec 31, 2021 | 12.49 Mn |
| Dec 31, 2020 | 11.53 Mn |
| Dec 31, 2020 | 11.53 Mn |
| Dec 31, 2019 | 234.50 Mn |
| Dec 31, 2019 | 234.50 Mn |
| Dec 31, 2018 | 188.02 Mn |
| Dec 31, 2018 | 188.02 Mn |
| Dec 31, 2017 | 34.66 Mn |
| Dec 31, 2017 | 34.66 Mn |
| Dec 31, 2016 | 12.22 Mn |
| Dec 31, 2016 | 12.22 Mn |